Stay updated on Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page's revision identifier was updated to v3.6.6, indicating a minor maintenance release of the page framework or content management system rather than substantive study changes.
    Difference
    0.0%
    Check dated 2026-09-01T19:44:19.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, representing a backend update to the page without changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T15:18:15.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4, replacing v3.6.3, indicating a small frontend/structural update to the study record display.
    Difference
    0.0%
    Check dated 2026-07-28T05:27:31.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.3, replacing the previous revision. This indicates a backend/platform update without changes to the study information presented.
    Difference
    0.0%
    Check dated 2026-07-06T16:42:25.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.2, reflecting a version update of the study details page metadata rather than substantive content changes. The core study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-29T08:45:08.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The page now clearly indicates that recruitment has ended by adding 'No longer looking for participants' and standardizes the 'Intervention/Treatment' header. New help and navigation sections were added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and the revision tag updated to v3.6.0, signaling a refreshed page presentation.
    Difference
    0.4%
    Check dated 2026-06-15T05:52:58.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.